 | Study programme 2025-2026 | Français | |
 | Les acides nucléiques, nouvelle source de thérapie personnalisée | ||
Programme component of Master's in Pharmacy (MONS) (day schedule)Faculty of Medicine, Pharmacy and Biomedical Sciences |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-018-M | Optional UE | COPPEE Frédérique | M122 - Biochimie métabolique et moléculaire |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-BIMO-005 | Les acides nucléiques, nouvelle source de thérapie personnalisée | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
The main objective of this course is to acquire the essential notions on the composition of nucleic acid-based drugs and their mode of action (MoA).
UE Content: description and pedagogical relevance
see the related AA
Prior Experience
Molecular biology concepts
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-BIMO-005 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-BIMO-005 |
|
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-BIMO-005 | powerpoint slides of the course |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-BIMO-005 | Not applicable |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-BIMO-005 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-BIMO-005 | Authorized |
Term 1 Assessment - type
| AA | Type(s) and mode(s) of Q1 assessment |
|---|---|
| M-BIMO-005 |
|
Term 1 Assessment - comments
| AA | Term 1 Assessment - comments |
|---|---|
| M-BIMO-005 | Assessment in the form of an assignment developing the composition and mode of action of a disease-specific nucleic acid drug described in a scientific article in English. |
Resit Assessment - Term 1 (BAB1) - type
| AA | Type(s) and mode(s) of Q1 resit assessment (BAB1) |
|---|---|
| M-BIMO-005 |
|
Resit Assessment - Term 1 (BAB1) - Comments
| AA | Resit Assessment - Term 1 (BAB1) - Comments |
|---|---|
| M-BIMO-005 | not applicable |
Term 3 Assessment - type
| AA | Type(s) and mode(s) of Q3 assessment |
|---|---|
| M-BIMO-005 |
|
Term 3 Assessment - comments
| AA | Term 3 Assessment - comments |
|---|---|
| M-BIMO-005 | Assessment in the form of an assignment developing the composition and mode of action of a disease-specific nucleic acid drug described in a scientific article in English. |
(*) HT : Hours of theory - HTPE : Hours of in-class exercices - HTPS : hours of practical work - HD : HMiscellaneous time - HR : Hours of remedial classes. - Per. (Period), Y=Year, Q1=1st term et Q2=2nd term